UPEXI commits to 1.25% annual market cap fee in stock for 3-year advisory deal
Summary
UPEXI signed a three-year advisory agreement with Hivemind Capital Partners, agreeing to pay an annual fee of 1.25% of its market capitalization in common stock, leading to continuous shareholder dilution.
Key Events
-
Advisory Services Agreement
UPEXI engaged Hivemind Capital Partners, LLC for a three-year term to provide advisory and consulting services on business, operations, and capital markets strategies, effective June 22, 2026.
-
Equity-Based Compensation
The advisor will receive an annual fee equal to 1.25% of UPEXI's market capitalization, payable quarterly in common stock. The first measurement date for this fee is June 30, 2026.
-
Ongoing Dilution
This recurring issuance of shares for advisory fees will lead to continuous dilution for existing shareholders over the three-year term, impacting the company's equity structure.
-
Significant Contingent Liability
The agreement stipulates that if UPEXI materially breaches the contract, it could be obligated to pay the full remaining three years of advisory fees in cash, representing a substantial financial commitment.
Analysis
UPEXI has entered a three-year advisory agreement with Hivemind Capital Partners, committing to an annual fee equivalent to 1.25% of its market capitalization, payable in common stock. This ongoing equity issuance will result in significant dilution for existing shareholders, especially given the company's recent substantial net losses. The agreement also includes a clause that could obligate UPEXI to pay the full remaining term's fees in cash if it breaches the contract, creating a notable contingent liability.
At the time of this filing, UPXI was trading at $0.76 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $53.4M. The 52-week trading range was $0.54 to $10.62. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.